Novo Nordisk CEO Mike Doustdar Talks Drug Sales
Bloomberg Talks5 Nov 2025

Novo Nordisk CEO Mike Doustdar Talks Drug Sales

Novo Nordisk has cut its forecast for the fourth time this year, after disappointing sales of its blockbuster drugs Wegovy and Ozempic. It underscores the challenges facing its new chief executive Mike Doustdar. He spoke to Bloomberg's Guy Johnson about the experience so far.

See omnystudio.com/listener for privacy information.

Avsnitt(2642)

Populärt inom Business & ekonomi

badfluence
framgangspodden
varvet
rss-jossan-nina
uppgang-och-fall
rss-borsens-finest
rss-svart-marknad
avanzapodden
fill-or-kill
lastbilspodden
bathina-en-podcast
borsmorgon
rss-inga-dumma-fragor-om-pengar
24fragor
rss-dagen-med-di
dynastin
rss-kort-lang-analyspodden-fran-di
tabberaset
loungepodden
rikatillsammans-om-privatekonomi-rikedom-i-livet